Disclosures for "Phase 1 Study of Gefurulimab Pharmacokinetics (PK) and Safety Following Delivery Via Autoinjector in Healthy Adults "
-
Dr. McEneny has received personal compensation for serving as an employee of Alexion Pharmaceuticals Inc.. Dr. McEneny has stock in Alexion Pharmaceuticals.
-
Mr. Cong has received personal compensation for serving as an employee of Alexion.
-
Dr. Yee has nothing to disclose.
-
Dr. Tong has received personal compensation for serving as an employee of Alexion Pharmaceuticals.